Reports- Monoclonal Antibody Market | Page 5

8.4.2.2 FAB
8.4.2.3 Variable Fragments
8.4.3 Novartis. 2015 Monoclonal Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Novartis. 2015 Monoclonal Antibody Business Region Distribution Analysis
8.5 AbbVie
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 MAB
8.5.2.2 FAB
8.5.2.3 Variable Fragments
8.5.3 AbbVie 2015 Monoclonal Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 AbbVie 2015 Monoclonal Antibody Business Region Distribution Analysis
8.6 Amgen
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 MAB
8.6.2.2 FAB
8.6.2.3 Variable Fragments
8.6.3 Amgen 2015 Monoclonal Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Amgen 2015 Monoclonal Antibody Business Region Distribution Analysis
8.7 Seattle Genetics
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 MAB
8.7.2.2 FAB
8.7.2.3 Variable Fragments
8.7.3 Seattle Genetics 2015 Monoclonal Antibody Sales, Ex-factory Price, Revenue, Gross Margin
Analysis
8.7.4 Seattle Genetics 2015 Monoclonal Antibody Business Region Distribution Analysis
8.8 Bristol-Myers Squibb
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 MAB
8.8.2.2 FAB
8.8.2.3 Variable Fragments
8.8.3 Bristol-Myers Squibb 2015 Monoclonal Antibody Sales, Ex-factory Price, Revenue, Gross
Margin Analysis
8.8.4 Bristol-Myers Squibb 2015 Monoclonal Antibody Business Region Distribution Analysis
8.9 Lilly
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 MAB
8.9.2.2 FAB
8.9.2.3 Variable Fragments
8.9.3 Lilly 2015 Monoclonal Antibody Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Lilly 2015 Monoclonal Antibody Business Region Distribution Analysis
8.10 Alexion Pharmaceuticals
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 MAB